메뉴 건너뛰기




Volumn 98, Issue 2, 2007, Pages 130-133

Prevalence and associated factors of hepatitis C infection (HCV) in a multi-site Canadian population of illicit opioid and other drug users (OPICAN)

Author keywords

Hepatitis C; Illicit drug use; Infectious disease; Logistic regression; Marginalization

Indexed keywords

STREET DRUG;

EID: 34249745255     PISSN: 00084263     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03404324     Document Type: Article
Times cited : (11)

References (43)
  • 1
    • 33646234738 scopus 로고    scopus 로고
    • Surveillance of hepatitis C infection among injecting drug users in the European Union
    • Jager J, Limburg W, Kretzschmar M, Postma M, Weissing L Eds, Luxembourg: European Monitoring Centre for Drugs and Drug Addiction
    • Wiessing L, Roy K, Sapinho D, Hay G, Taylor A, Goldberg D, et al. Surveillance of hepatitis C infection among injecting drug users in the European Union. In: Jager J, Limburg W, Kretzschmar M, Postma M, Weissing L (Eds.), EMCDDA Monographs: Hepatitis C and Injection Drug Use: Impact, Costs and Policy Options. Luxembourg: European Monitoring Centre for Drugs and Drug Addiction, 2004;91-135.
    • (2004) EMCDDA Monographs: Hepatitis C and Injection Drug Use: Impact, Costs and Policy Options , pp. 91-135
    • Wiessing, L.1    Roy, K.2    Sapinho, D.3    Hay, G.4    Taylor, A.5    Goldberg, D.6
  • 2
    • 4344576522 scopus 로고    scopus 로고
    • Injection drug use and the hepatitis C virus: Considerations for a targeted treatment approach-The case study of Canada
    • Fischer B, Haydon E, Rehm J, Krajden M, Reimer J. Injection drug use and the hepatitis C virus: Considerations for a targeted treatment approach-The case study of Canada. J Urban Health 2004;81:428-47.
    • (2004) J Urban Health , vol.81 , pp. 428-447
    • Fischer, B.1    Haydon, E.2    Rehm, J.3    Krajden, M.4    Reimer, J.5
  • 3
    • 0035811625 scopus 로고    scopus 로고
    • Hepatitis C virus infection
    • Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001;345:41-52.
    • (2001) N Engl J Med , vol.345 , pp. 41-52
    • Lauer, G.M.1    Walker, B.D.2
  • 4
    • 0033765925 scopus 로고    scopus 로고
    • Current status of hepatitis C in Canada
    • Zou S, Tepper M, Giulivi A. Current status of hepatitis C in Canada. Can J Public Health 2000;91(Suppl. 1):S10-S15.
    • (2000) Can J Public Health , vol.91 , Issue.SUPPL. 1
    • Zou, S.1    Tepper, M.2    Giulivi, A.3
  • 7
    • 16844367232 scopus 로고    scopus 로고
    • Epidemiology and natural history of Hepatitis C virus infection in injection drug users: Implications for treatment
    • Sulkowski M, Thomas D. Epidemiology and natural history of Hepatitis C virus infection in injection drug users: Implications for treatment. Clin Infect Dis 2005;40:S263-S269.
    • (2005) Clin Infect Dis , vol.40
    • Sulkowski, M.1    Thomas, D.2
  • 8
    • 0036532253 scopus 로고    scopus 로고
    • Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment
    • Thorpe LE, Ouellet LJ, Hershow R, Bailey SL, Williams IT, Williamson J, et al. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol 2002;155:645-53.
    • (2002) Am J Epidemiol , vol.155 , pp. 645-653
    • Thorpe, L.E.1    Ouellet, L.J.2    Hershow, R.3    Bailey, S.L.4    Williams, I.T.5    Williamson, J.6
  • 11
    • 0035174306 scopus 로고    scopus 로고
    • Factors associated with prevalent hepatitis C: Differences among young adult injection drug users in lower and upper Manhattan, New York City
    • Diaz T, Des Jarlais D, Vlahov D, Perlis TE, Edwards V, Friedman SR, et al. Factors associated with prevalent hepatitis C: Differences among young adult injection drug users in lower and upper Manhattan, New York City. Am J Public Health 2001;91:23-30.
    • (2001) Am J Public Health , vol.91 , pp. 23-30
    • Diaz, T.1    Des Jarlais, D.2    Vlahov, D.3    Perlis, T.E.4    Edwards, V.5    Friedman, S.R.6
  • 12
    • 0042805241 scopus 로고    scopus 로고
    • Hepatitis C virus infection in injection drug users in Bavaria: Risk factors for seropositivity
    • Backmund M, Meyer K, Wachtler M, Eichenlaub D. Hepatitis C virus infection in injection drug users in Bavaria: Risk factors for seropositivity. Eur J Epidemiol 2003;18:563-68.
    • (2003) Eur J Epidemiol , vol.18 , pp. 563-568
    • Backmund, M.1    Meyer, K.2    Wachtler, M.3    Eichenlaub, D.4
  • 13
    • 0029867968 scopus 로고    scopus 로고
    • Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses
    • Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health 1996;86:655-61.
    • (1996) Am J Public Health , vol.86 , pp. 655-661
    • Garfein, R.S.1    Vlahov, D.2    Galai, N.3    Doherty, M.C.4    Nelson, K.E.5
  • 14
    • 0035661177 scopus 로고    scopus 로고
    • Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection
    • Patrick DM, Tyndall MW, Cornelisse PG, Li K, Sherlock CH, Rekart ML, et al. Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection. CAMJ 2001;165:889-95.
    • (2001) CAMJ , vol.165 , pp. 889-895
    • Patrick, D.M.1    Tyndall, M.W.2    Cornelisse, P.G.3    Li, K.4    Sherlock, C.H.5    Rekart, M.L.6
  • 16
    • 1642294078 scopus 로고    scopus 로고
    • Sharing of noninjection drug-use implements as a risk factor for hepatitis C
    • Tortu S, McMahon J, Pouget E, Hamid R. Sharing of noninjection drug-use implements as a risk factor for hepatitis C. Subst Use Misuse 2004;39:211-24.
    • (2004) Subst Use Misuse , vol.39 , pp. 211-224
    • Tortu, S.1    McMahon, J.2    Pouget, E.3    Hamid, R.4
  • 18
    • 0027498436 scopus 로고
    • Hepatitis C virus infection among patients attending a clinic for sexually transmitted diseases
    • Weinstock HS, Bolan G, Reingold AL, Polish LB. Hepatitis C virus infection among patients attending a clinic for sexually transmitted diseases. JAMA 1993;269:392-94.
    • (1993) JAMA , vol.269 , pp. 392-394
    • Weinstock, H.S.1    Bolan, G.2    Reingold, A.L.3    Polish, L.B.4
  • 19
    • 0033799253 scopus 로고    scopus 로고
    • Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus
    • Sulkowski MS, Mast EE, Seeff LB, Thomas DL. Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus. Clin Infect Dis 2000;30:S77-S84.
    • (2000) Clin Infect Dis , vol.30
    • Sulkowski, M.S.1    Mast, E.E.2    Seeff, L.B.3    Thomas, D.L.4
  • 20
    • 3042633959 scopus 로고    scopus 로고
    • Correlates of hepatitis C virus infection in homeless men: A latent variable approach
    • Stein JA, Nyamathi A. Correlates of hepatitis C virus infection in homeless men: A latent variable approach. Drug Alcohol Depend 2004;75:89-95.
    • (2004) Drug Alcohol Depend , vol.75 , pp. 89-95
    • Stein, J.A.1    Nyamathi, A.2
  • 22
    • 21844431859 scopus 로고    scopus 로고
    • Hepatitis C virus infection among prisoners in the California state correctional system
    • Fox RK, Currie SL, Evans J, Wright TL, Tobler L, Phelps B, et al. Hepatitis C virus infection among prisoners in the California state correctional system. Clin Infect Dis 2005;41:177-86.
    • (2005) Clin Infect Dis , vol.41 , pp. 177-186
    • Fox, R.K.1    Currie, S.L.2    Evans, J.3    Wright, T.L.4    Tobler, L.5    Phelps, B.6
  • 23
    • 0035378571 scopus 로고    scopus 로고
    • High prevalence of hepatitis C infection in a Brazilian prison: Identification of risk factors for infection
    • Guimaraes T, Granato CF, Varella D, Ferraz ML, Castelo A, Kallas EG. High prevalence of hepatitis C infection in a Brazilian prison: Identification of risk factors for infection. Braz J Infect Dis 2001;5:111-18.
    • (2001) Braz J Infect Dis , vol.5 , pp. 111-118
    • Guimaraes, T.1    Granato, C.F.2    Varella, D.3    Ferraz, M.L.4    Castelo, A.5    Kallas, E.G.6
  • 24
    • 0036890620 scopus 로고    scopus 로고
    • Hepatitis C virus seroconversion among young injection drug users: Relationships and risks
    • Hahn JA, Page-Shafer K, Lum PJ, Bourgois P, Stein E, Evans JL, et al. Hepatitis C virus seroconversion among young injection drug users: Relationships and risks. J Infect Dis 2002; 186:1558-64.
    • (2002) J Infect Dis , vol.186 , pp. 1558-1564
    • Hahn, J.A.1    Page-Shafer, K.2    Lum, P.J.3    Bourgois, P.4    Stein, E.5    Evans, J.L.6
  • 25
    • 14544298932 scopus 로고    scopus 로고
    • Hepatitis C virus incidence among injecting drug users on opioid replacement therapy
    • Hallinan R, Byrne A, Amin J, Dore GJ. Hepatitis C virus incidence among injecting drug users on opioid replacement therapy. Aust N Z J Public Health 2004;28:576-78.
    • (2004) Aust N Z J Public Health , vol.28 , pp. 576-578
    • Hallinan, R.1    Byrne, A.2    Amin, J.3    Dore, G.J.4
  • 26
    • 34249826765 scopus 로고    scopus 로고
    • National Institutes of Health. Management of hepatitis C: 2002. Final Statement. Washington, National Institutes of Health, 2002.
    • National Institutes of Health. Management of hepatitis C: 2002. Final Statement. Washington, National Institutes of Health, 2002.
  • 27
    • 29244434415 scopus 로고    scopus 로고
    • The impact and cost-effectiveness of methadone maintenance treatment in preventing HIV and Hepatitis C
    • Jager J, Limburg W, Kretzschmar M, Postma M, Weissing L Eds, Luxembourg: EMCDDA
    • Pollack H, Heimer R. The impact and cost-effectiveness of methadone maintenance treatment in preventing HIV and Hepatitis C. In: Jager J, Limburg W, Kretzschmar M, Postma M, Weissing L (Eds.), EMCDDA Monographs: Hepatitis C and injecting drug use: impact, costs and policy options. Luxembourg: EMCDDA, 2004;345-67.
    • (2004) EMCDDA Monographs: Hepatitis C and injecting drug use: impact, costs and policy options , pp. 345-367
    • Pollack, H.1    Heimer, R.2
  • 28
    • 24044449243 scopus 로고    scopus 로고
    • Illicit opioid use in Canada: Comparing social, health and drug use characteristics of untreated users in five cities (OPICAN study)
    • Fischer B, Rehm J, Brissette S, Brochu. S, Bruneau J, el-Guebaly N, et al. Illicit opioid use in Canada: Comparing social, health and drug use characteristics of untreated users in five cities (OPICAN study). J Urban Health 2005;82:250-66.
    • (2005) J Urban Health , vol.82 , pp. 250-266
    • Fischer, B.1    Rehm, J.2    Brissette, S.3    Brochu, S.4    Bruneau, J.5    el-Guebaly, N.6
  • 29
    • 0003794238 scopus 로고    scopus 로고
    • Version] 12
    • SPSS for Windows [Version] 12, 2005.
    • (2005) SPSS for Windows
  • 30
    • 0031807856 scopus 로고    scopus 로고
    • Hepatitis C virus transmission dynamics in injection drug users
    • Hagan H. Hepatitis C virus transmission dynamics in injection drug users. Subst Use Misuse 1998;33:1197-212.
    • (1998) Subst Use Misuse , vol.33 , pp. 1197-1212
    • Hagan, H.1
  • 32
    • 0040524323 scopus 로고    scopus 로고
    • Needle exchange, HIV infection, and the politics of science: Confronting Canada's cocaine injection epidemic with participant observation
    • Bourgois P, Bruneau J. Needle exchange, HIV infection, and the politics of science: Confronting Canada's cocaine injection epidemic with participant observation. Med Anthropol 2000;18:325-50.
    • (2000) Med Anthropol , vol.18 , pp. 325-350
    • Bourgois, P.1    Bruneau, J.2
  • 33
    • 0027261005 scopus 로고
    • HIV risk-related sex behaviors among injection drug users, crack smokers, and injection drug users who smoke crack
    • Booth R, Watters J, Chitwood D. HIV risk-related sex behaviors among injection drug users, crack smokers, and injection drug users who smoke crack. Am J Public Health 1993;83:1144-48.
    • (1993) Am J Public Health , vol.83 , pp. 1144-1148
    • Booth, R.1    Watters, J.2    Chitwood, D.3
  • 34
    • 4344669262 scopus 로고    scopus 로고
    • Risk factors for hepatitis C infection and perception of antibody status among male prison inmates in the Hepatitis C Incidence and Transmission in Prisons Study Cohort, Australia
    • Gates J, Post J, Kaldor J, Pan Y, Haber P, Lloyd A, et al. Risk factors for hepatitis C infection and perception of antibody status among male prison inmates in the Hepatitis C Incidence and Transmission in Prisons Study Cohort, Australia. J Urban Health 2004;81:448-52.
    • (2004) J Urban Health , vol.81 , pp. 448-452
    • Gates, J.1    Post, J.2    Kaldor, J.3    Pan, Y.4    Haber, P.5    Lloyd, A.6
  • 35
    • 16844382462 scopus 로고    scopus 로고
    • Treating hepatitis C virus infection in active substance users
    • Sylvestre DL. Treating hepatitis C virus infection in active substance users. Clin Infect Dis 2005;40(Suppl 5):S321-S324.
    • (2005) Clin Infect Dis , vol.40 , Issue.SUPPL. 5
    • Sylvestre, D.L.1
  • 36
    • 16844383879 scopus 로고    scopus 로고
    • Hepatitis C virus infection and injection drug users: Prevention, risk factors, and treatment
    • Backmund M, Reimer J, Meyer K, Gerlach JT, Reinhart Z. Hepatitis C virus infection and injection drug users: Prevention, risk factors, and treatment. Clin Infect Dis 2005;40(Suppl 5):S330-S335.
    • (2005) Clin Infect Dis , vol.40 , Issue.SUPPL. 5
    • Backmund, M.1    Reimer, J.2    Meyer, K.3    Gerlach, J.T.4    Reinhart, Z.5
  • 37
    • 16844386660 scopus 로고    scopus 로고
    • Hepatitis C virus infection and substance abuse: Medical management and developing models of integrated care-An introduction
    • Kresina T, Khalsa J, Cesari H, Francis H. Hepatitis C virus infection and substance abuse: Medical management and developing models of integrated care-An introduction. Clin Infect Dis 2005; 40:S259-S262.
    • (2005) Clin Infect Dis , vol.40
    • Kresina, T.1    Khalsa, J.2    Cesari, H.3    Francis, H.4
  • 39
    • 0034802218 scopus 로고    scopus 로고
    • Estimating progression to cirrhosis in chronic hepatitis C virus infection
    • Freeman AJ, Dore GJ, Law MG, Thorpe M, Von OJ, Lloyd AR, et al. Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology 2001;34:809-16.
    • (2001) Hepatology , vol.34 , pp. 809-816
    • Freeman, A.J.1    Dore, G.J.2    Law, M.G.3    Thorpe, M.4    Von, O.J.5    Lloyd, A.R.6
  • 40
    • 0032143928 scopus 로고    scopus 로고
    • Self-report among injecting drug users: A review
    • Darke S. Self-report among injecting drug users: A review. Drug Alcohol Depend 1998;51:253-62.
    • (1998) Drug Alcohol Depend , vol.51 , pp. 253-262
    • Darke, S.1
  • 42
    • 0033724990 scopus 로고    scopus 로고
    • Hepatitis C virus infection: Prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997-1999
    • Thorpe LE, Ouellet LJ, Levy JR, Williams IT, Monterroso ER. Hepatitis C virus infection: Prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997-1999. J Infect Dis 2000;182:1588-94.
    • (2000) J Infect Dis , vol.182 , pp. 1588-1594
    • Thorpe, L.E.1    Ouellet, L.J.2    Levy, J.R.3    Williams, I.T.4    Monterroso, E.R.5
  • 43
    • 33748604198 scopus 로고    scopus 로고
    • Hepatitis C, illicit drug use and public health: Does Canada really have a viable plan?
    • Fischer B, Kalousek K, Rehm J, Powis J, Krajden M, Reimer J. Hepatitis C, illicit drug use and public health: Does Canada really have a viable plan? Can J Public Health 2006;97(6):485-88.
    • (2006) Can J Public Health , vol.97 , Issue.6 , pp. 485-488
    • Fischer, B.1    Kalousek, K.2    Rehm, J.3    Powis, J.4    Krajden, M.5    Reimer, J.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.